Japanese Simple Chinese Traditional Chinese Korean

Day 1
Day 2
Welcome Letter
Distinguished Faculty
Drug Safety Book Promotion
Hotel & Travel
Download PDF
Press Pass 
Request Brochure 




Science AAAS logo

The Scientist

BMI logo

Center Watch Classic

Drug Safety Logo

Pharma Insight



Innovaro Pharmalicensing

Pharm Cast



Register Today!


Better Integrating Clinical and Preclinical Safety to Achieve Translational Safety

James Milligan, M.D., Safety Science Expert/Safety Physician, Clinical Safety, AstraZeneca

Idiosyncratic DILI: How Good are Currently Available Biomarkers and Which New Biomarkers Should We Look for?

Arie Regev M.D., Chair, Liver and GI Safety Committee, Global Patient Safety, Eli Lilly & Company

Bridging the Gap between Preclinical Data, Clinical Studies and Post-Approval Drug Safety

Phil Sager, M.D., Vice President, Clinical Research, Head, CV/Metabolic Clinical Development, Gilead

Achieving the Promise of Translational Research: Overcoming Scientific and Organization Challenges to Improve Early Risk Assessment

Stephen Furlong, Ph.D., Safety Science Lead, US Patient Safety, AstraZeneca

Idiosyncratic Liver Injury: Challenges and Approaches

Paul Watkins, M.D., Verne S. Caviness Distinguished Professor of Medicine, Professor of Pharmacotherapy, University of North Carolina Chapel Hill

Use of Informatics Approaches for Establishing a Threshold of Toxicological Concern

Sandeep Modi, Ph.D., Cheminformatician, Safety & Environmental Assurance Centre, Unilever; former Research Associate, GlaxoSmithKline

Special Panel hosted by DSEC: What Predictive Safety Technologies are Being Utilized Upstream and How They May Impact Clinical and Post-Approval Safety

Interactive Breakout Discussion Groups



Complimentary Webinar 

Keys to Gaining Widespread Adoption of Your Predictive Safety Platform

Wednesday, September 8 - 11:00 a.m. - 12:00 p.m. (EDT)